Medical Equipment

Revenue of the DNA And Gene Chip Market Predicted to Achieve $16.98 Billion by 2030, Driven by 12.9% CAGR

February 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the DNA And Gene Chip Market in 2026, and what figure is it projected to hit by 2030?_x000D_

The dna and gene chip market has observed swift expansion in recent years. This market is projected to increase from $9.2 billion in 2025 to $10.45 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.6%. The historical growth can be linked to the broadening of genomic research activities, a greater embrace of molecular diagnostics, the development of cancer research programs, the increasing accessibility of advanced microarray platforms, and an expansion of academic genomics funding._x000D_

_x000D_

The dna and gene chip market is projected for substantial expansion in the coming years, set to reach $16.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This projected growth over the forecast period stems from factors such as a heightened emphasis on personalized medicine, increased capital expenditure in genomics-driven drug discovery, the broadening scope of population-wide genetic screening, the expanding integration of AI in genomic analytics, and the wider application of gene chips in agrigenomics. Key developments anticipated during this period encompass the wider deployment of high-density gene expression arrays, an uptick in the utilization of single-cell analysis chips, a rising need for precision oncology diagnostic tools, the proliferation of SNP and whole genome analysis chips, and a stronger emphasis on high-throughput genomic screening methods._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp_x000D_

_x000D_

Which Drivers Are Affecting Market Participation In The DNA And Gene Chip Market?_x000D_

The increasing requirement for early cancer identification is significantly fostering the expansion of the DNA and gene market. Cancer refers to a diverse category of conditions that can arise in almost any body organ or tissue when abnormal cells multiply uncontrollably, breach normal cellular boundaries to invade nearby organs, and spread to other parts of the body. The growing awareness regarding the benefits of detecting cancer at an initial stage is driving the increased demand for early cancer detection, leading individuals to seek timely screening, which improves treatment outcomes and survival chances. DNA and gene chips are employed to measure gene expression patterns, determine the genetic and epigenetic landscape, and measure genomic regulatory elements bound by cancer transcription factors in cancerous cells. For instance, in May 2025, according to a report published by the National Cancer Institute (NCI), a US-based federal government agency, in 2025, the United States is expected to see about 2,041,910 new cancer cases and approximately 618,120 deaths from the disease. Therefore, the escalating demand for early cancer detection is driving the growth of the DNA and gene chip market._x000D_

_x000D_

What Segment Categories Are Covered In The DNA And Gene Chip Market?_x000D_

The dna and gene chip market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA)_x000D_

2) By Application: Cancer Diagnostics, Gene Expression, Genomics, Drug Discovery, Agrigenomics_x000D_

3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays_x000D_

2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays_x000D_

_x000D_

What Trends Are Driving The Growth Trajectory Of The DNA And Gene Chip Market?_x000D_

Major companies within the DNA and gene chip market are actively developing innovative genotyping chips, such as Axiom YNS_Mol1, to advance the food industry and broaden the acceptance of insect consumption. Axiom YNS_Mol1 is specifically designed as a genotyping chip for insect breeding, particularly focusing on the Tenebrio Molitor mealworm. As an illustration, in June 2023, Ÿnsect, a France-based company specializing in insect production, introduced the world’s inaugural genotyping chip for insect breeding, named Axiom YNS_Mol1. This groundbreaking genotyping chip was developed in partnership with Thermo Fisher Scientific, with the goal of revolutionizing insect breeding for sustainable food and pet food options. The chip operates by analyzing genetic characteristics, thereby promoting genomic diversity and improving traits such as growth, reproduction, and disease resistance in Tenebrio Molitor mealworms. This innovative development forms part of Ÿnsect’s ŸnFABRE project, contributing to the progression of entomoculture and the development of sustainable solutions in response to environmental challenges._x000D_

_x000D_

Which Leading Companies Dominate The DNA And Gene Chip Market Share?_x000D_

Major companies operating in the dna and gene chip market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., CapitalBio Corporation, Microarrays Inc., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Fluidigm Corporation, LC Sciences, Macrogen Inc., Greiner Bio-One International GmbH, F. Hoffmann-La Roche Ltd, GE Healthcare, Hitachi High-Technologies Corporation _x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report_x000D_

_x000D_

Which Region Is Anticipated To See The Fastest Growth In The DNA And Gene Chip Market?_x000D_

North America was the largest region in the DNA and gene chip market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized DNA And Gene Chip Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global DNA And Gene Chip Market 2026, By The Business Research Company#_x000D_

_x000D_

Consumer Genomics Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report_x000D_

_x000D_

Recombinant Dna Technology Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report_x000D_

_x000D_